Rigel Pharmaceuticals earnings were $3.9M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest RIGL earnings report on Sep 30, 2024 announced Q3 2024 earnings of $12.4M, down 1,305.9% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, RIGL reported annual earnings of -$25.1M, with -57.2% growth. The next RIGL earnings date is Mar 3, 2025.
Rigel Pharmaceuticals Earnings Reports & History FAQ
What were Rigel Pharmaceuticals's earnings last quarter?
On RIGL's earnings call on Invalid Date, Rigel Pharmaceuticals (NASDAQ: RIGL) reported Q3 2024 earnings per share (EPS) of $0.71, up 315.15% year over year. Total RIGL earnings for the quarter were $12.42 million. In the same quarter last year, Rigel Pharmaceuticals's earnings per share (EPS) was -$0.33.
The next RIGL earnings date is Invalid Date. Add RIGL to your watchlist to be reminded of Rigel Pharmaceuticals's next earnings date.
What was RIGL's earnings growth in the past year?
As of Rigel Pharmaceuticals's earnings date in Invalid Date, Rigel Pharmaceuticals's earnings has grown year over year. RIGL earnings in the past year totalled $3.88 million.
Is Rigel Pharmaceuticals profitable or losing money?
As of the last Rigel Pharmaceuticals earnings report, Rigel Pharmaceuticals is currently profitable. Rigel Pharmaceuticals's net profit (also called net income) for the twelve months ending Sep 30, 2024 was $3.88 million, a 115.89% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.